40 results
8-K
EX-10.1
PRLD
Prelude Therapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:05pm
Wilmington, Delaware 19805 USA
Attn: Contracts Department
contracts@preludetx.com
Consultant: Laurent Chardonnet
737 Kennett Pike
Chadds Ford, PA 19317
8-K
EX-4.1
PRLD
Prelude Therapeutics Inc
11 Dec 23
Prelude Therapeutics Announces $25 Million Private Placement
9:17am
, an unincorporated organization, any other entity and a government or any department or agency thereof.
(g) “Principal Trading Market” means the national
424B5
4dpr2wzexx bni5
19 May 23
Prospectus supplement for primary offering
4:09pm
8-K
EX-1.1
7hyl slag0btx
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
8-K
EX-4.1
3xqcjjo6q
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
424B5
zm8qy h0hxk9k
17 May 23
Prospectus supplement for primary offering
4:26pm
PRE 14A
llnhfvpnxz4muxmx0m
18 Apr 23
Preliminary proxy
4:00pm
S-3
EX-4.5
qyi780fejitrq
12 Nov 21
Shelf registration
4:02pm